CDC25C and cancer: Along with genomic and deep learning analyses biomolecular markers, potentially CDC25, can be used as predictive measures for predictive biomarkers for treatment outcomes and recurrence risk in cancers, emphasizing the need for further multicentred investigations (Nakano et al., 2023).